Stockreport

Biotech: Halozyme CEO explains what it looks for in M&A targets [Yahoo! Finance Canada]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF M&A activity in the biotech industry has been forecasted to accelerate in 2026. Dr. Helen Torley, the CEO and president of Halozyme, explains to Julie Hyman the charac [Read more]